MedTrace Logo

Performance Study of New Media for Vitrification of Human Oocytes

NCT01481571 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2014-03-24

No results posted yet for this study

Summary

The purpose of this study is to evaluate safety and performance of Vitrolife´s new oocyte vitrification/warming media and the vitrification device Rapid-i™, when using vitrification as a cryopreservation method for human oocytes.

Conditions

Interventions

DEVICE

Vitrification medium oocyte, warming medium oocyte and Rapid-i

Media and device for vitrification of human oocytes

Sponsors & Collaborators

  • Vitrolife

    lead INDUSTRY

Principal Investigators

  • Marius Meintjes, Dr

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
37 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-08-31
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01481571 on ClinicalTrials.gov